Atlas Trials

Systems Biological Analysis of Immune Responses to RSV Vaccine

Clinical trial NCT07185399 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07185399
Sponsor
Emory University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Respiratory Syncytial Virus (RSV)
Start date
2025-10-13
Primary completion
2027-01-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.